TransThera Sciences (Nanjing), Inc. (HKG:2617)
Hong Kong
· Delayed Price · Currency is HKD 54.70
-1.60 (-2.84%)
Apr 29, 2026, 4:08 PM HKT
HKG:2617 Market Cap
HKG:2617 has a market cap or net worth of 22.10 billion as of April 29, 2026.
Market Cap
22.10B
Enterprise Value
21.56B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
54.70
Market Cap Chart
Since June 23, 2025, HKG:2617's market cap has increased from 9.33B to 22.10B, an increase of 136.98%. That is a compound annual growth rate of 177.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 22.75B | -50.11% |
| Dec 31, 2025 | 45.60B | 388.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Keymed Biosciences | 22.17B |
| Duality Biotherapeutics | 25.29B |
| Shanghai Bao Pharmaceuticals | 25.75B |
| Zai Lab | 19.49B |
| InnoCare Pharma | 28.40B |
| Ascletis Pharma | 17.70B |
| Genscript Biotech | 29.60B |
| Ascentage Pharma Group International | 16.91B |